A comparison of methods for analyzing a binary composite endpoint with partially observed components in randomized controlled trials

被引:2
作者
Tra My Pham [1 ]
White, Ian R. [1 ]
Kahan, Brennan C. [1 ]
Morris, Tim P. [1 ]
Stanworth, Simon J. [2 ,3 ]
Forbes, Gordon [4 ]
机构
[1] UCL, Inst Clin Trials & Methodol, MRC Clin Trials Unit, 90 High Holborn, London WC1V 6LJ, England
[2] Oxford Univ Hosp, NHS Blood & Transplant, Oxford, England
[3] Univ Oxford, Oxford, England
[4] Kings Coll London, Biostat & Hlth Informat Dept, London, England
基金
英国医学研究理事会;
关键词
compatibility; composite endpoints; missing data; multiple imputation; RCTs; MULTIPLE-IMPUTATION;
D O I
10.1002/sim.9203
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Composite endpoints are commonly used to define primary outcomes in randomized controlled trials. A participant may be classified as meeting the endpoint if they experience an event in one or several components (eg, a favorable outcome based on a composite of being alive and attaining negative culture results in trials assessing tuberculosis treatments). Partially observed components that are not missing simultaneously complicate the analysis of the composite endpoint. An intuitive strategy frequently used in practice for handling missing values in the components is to derive the values of the composite endpoint from observed components when possible, and exclude from analysis participants whose composite endpoint cannot be derived. Alternatively, complete record analysis (CRA) (excluding participants with any missing components) or multiple imputation (MI) can be used. We compare a set of methods for analyzing a composite endpoint with partially observed components mathematically and by simulation, and apply these methods in a reanalysis of a published trial (TOPPS). We show that the derived composite endpoint can be missing not at random even when the components are missing completely at random. Consequently, the treatment effect estimated from the derived endpoint is biased while CRA results without the derived endpoint are valid. Missing at random mechanisms require MI of the components. We conclude that, although superficially attractive, deriving the composite endpoint from observed components should generally be avoided. Despite the potential risk of imputation model mis-specification, MI of missing components is the preferred approach in this study setting.
引用
收藏
页码:6634 / 6650
页数:17
相关论文
共 28 条
[1]  
[Anonymous], 2013, Multiple imputation and its application
[2]   Multiple imputation of covariates by fully conditional specification: Accommodating the substantive model [J].
Bartlett, Jonathan W. ;
Seaman, Shaun R. ;
White, Ian R. ;
Carpenter, James R. .
STATISTICAL METHODS IN MEDICAL RESEARCH, 2015, 24 (04) :462-487
[3]   Robustness of a multivariate normal approximation for imputation of incomplete binary data [J].
Bernaards, Coen A. ;
Belin, Thomas R. ;
Schafer, Joseph L. .
STATISTICS IN MEDICINE, 2007, 26 (06) :1368-1382
[4]   Quality of reporting of outcomes in phase III studies of pulmonary tuberculosis: a systematic review [J].
Bonnett, Laura Jayne ;
Ken-Dror, Gie ;
Davies, Geraint Rhys .
TRIALS, 2018, 19
[5]   MULTIPLE IMPUTATION FOR NONRESPONSE IN SURVEYS - RUBIN,DB [J].
CAMPION, WM .
JOURNAL OF MARKETING RESEARCH, 1989, 26 (04) :485-486
[6]   Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review [J].
Cordoba, Gloria ;
Schwartz, Lisa ;
Woloshin, Steven ;
Bae, Harold ;
Gotzsche, Peter C. .
BMJ-BRITISH MEDICAL JOURNAL, 2010, 341 :381
[7]   Efficient estimation of the distribution of time to composite endpoint when some endpoints are only partially observed [J].
Daniel, Rhian M. ;
Tsiatis, Anastasios A. .
LIFETIME DATA ANALYSIS, 2013, 19 (04) :513-546
[8]   Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials [J].
Ferreira-Gonzalez, I. ;
Busse, J. W. ;
Heels-Ansdell, D. ;
Montori, V. M. ;
Akl, E. A. ;
Bryant, D. M. ;
Alonso, J. ;
Jaeschke, R. ;
Schuenemann, H. J. ;
Permanyer-Miralda, G. ;
Domingo-Salvany, A. ;
Guyatt, G. H. .
BMJ-BRITISH MEDICAL JOURNAL, 2007, 334 (7597) :786-788A
[9]   Drug-resistant tuberculosis clinical trials: proposed core research definitions in adults [J].
Furin, J. ;
Alirol, E. ;
Allen, E. ;
Fielding, K. ;
Merle, C. ;
Abubakar, I. ;
Andersen, J. ;
Davies, G. ;
Dheda, K. ;
Diacon, A. ;
Dooley, K. E. ;
Dravnice, G. ;
Eisenach, K. ;
Everitt, D. ;
Ferstenberg, D. ;
Goolam-Mahomed, A. ;
Grobusch, M. P. ;
Gupta, R. ;
Harausz, E. ;
Harrington, M. ;
Horsburgh, C. R. ;
Lienhardt, C. ;
McNeeley, D. ;
Mitnick, C. D. ;
Nachman, S. ;
Nahid, P. ;
Nunn, A. J. ;
Phillips, P. ;
Rodriguez, C. ;
Shah, S. ;
Wells, C. ;
Thomas-Nyang'wa, B. ;
du Cros, R. .
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2016, 20 (03) :290-294
[10]   A potential for bias when rounding in multiple imputation [J].
Horton, NJ ;
Lipsitz, SR ;
Parzen, M .
AMERICAN STATISTICIAN, 2003, 57 (04) :229-232